Taizhou, Jiangsu, China, 7 April 2009 – Jiangsu government’s China Medical City (CMC) and Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com) broke ground on the 20,000 square-meter Stem Cell Regenerative Medicine…
Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell
Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…
Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.
SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ — Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), China’s leading stem cell research and regenerative medicine company, announced that it has entered into an agreement…
American Toddler Sees Dramatic Improvement from Beike Biotechnology Stem Cell Treatment
SHENZHEN, China, Aug. 14 /PRNewswire-USNewswire/ — Shenzhen Beike Biotechnology Co., Ltd. (https://www.beikebiotech.com) today announced the successful treatment with umbilical cord stem cells of three-and-a-half-year- old American toddler Lukas Nguyen. At…
Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
Beike Biotechnology Co., Ltd. today announced that a team led by Dr. Yang Xiaofeng at its collaborating hospital in Shenyang completed a study to assess clinical efficacy, safety, and feasibility…
A Tale of Two Spinal Cord Injury Patients
Shenzhen, China –- June 16th, 2006 — Shenzhen Beike Biotechnology Co., Ltd has announced the successful treatment of two spinal cord injury patients with different methods for treatment – one…